IX Acquisition (IXAQ)
Search documents
IX Acquisition (IXAQ) - 2023 Q1 - Quarterly Report
2023-05-22 21:03
Financial Performance - For the three months ended March 31, 2023, the company reported a net income of approximately $1.5 million, driven by $2.1 million in income from investments held in the Trust Account[125]. - The company incurred approximately $278,000 in operating and formation expenses for the three months ended March 31, 2023[125]. - The company had a working capital deficit of approximately $996,000 as of March 31, 2023[116]. Initial Public Offering - The company completed its Initial Public Offering on October 12, 2021, raising total gross proceeds of $230 million from the sale of 23 million Units[112]. - The underwriters of the Initial Public Offering fully exercised their over-allotment option, generating additional gross proceeds of $30 million[129]. Trust Account and Liquidity - As of March 31, 2023, the company had approximately $236.5 million in cash held in the Trust Account, intended for the initial Business Combination[119]. - The company plans to use substantially all funds in the Trust Account for the initial Business Combination and subsequent operations[119]. - The company has a liquidity condition that raises substantial doubt about its ability to continue as a going concern for one year after the issuance of its financial statements[121]. Business Combination - The company has until April 12, 2024, to consummate a Business Combination, or it will face mandatory liquidation[120]. - The company has not yet selected a Business Combination target and has not initiated substantive discussions with any potential targets[111]. Shareholder Actions - On April 10, 2023, shareholders approved the Extension Proposal, Founder Share Amendment Proposal, and Redemption Limitation Amendment Proposal[141]. - 18,336,279 Class A ordinary shares were redeemed at approximately $10.30 per share, totaling an aggregate redemption amount of approximately $189 million, leaving approximately $48 million in the Trust Account[142]. Sponsor Contributions - The Sponsor agreed to deposit a loan of up to $1 million into the Trust Account, with the first contribution of $160,000 made on April 13, 2023[144][145]. - The Board of Directors extended the Extended Date from May 12, 2023, to June 12, 2023, and requested an additional drawdown of $160,000 under the Extension Promissory Note[145]. - The Sponsor converted 4,002,121 Class B ordinary shares into Class A ordinary shares, resulting in a total of 8,665,842 Class A ordinary shares and 1,747,879 Class B ordinary shares outstanding[146].
IX Acquisition (IXAQ) - 2022 Q4 - Annual Report
2023-04-17 21:20
Financial Performance - For the year ended December 31, 2022, the company reported a net income of approximately $9.3 million, influenced by a $7.5 million gain from the change in fair value of derivative warrant liabilities[272][281]. - The company reported a net income of $9,286,803 for the year ended December 31, 2022, compared to a net income of $9,337,120 for the period from March 1, 2021, through December 31, 2021[316]. - Basic net income per share for Class A ordinary shares was $0.32 for the year ended December 31, 2022, and $0.84 for the period from March 1, 2021, through December 31, 2021[316]. - The allocation of net income for Class A ordinary shares was $7,429,442 and for Class B was $1,857,361 for the year ended December 31, 2022[369]. - For the year ended December 31, 2022, the basic net income per ordinary share for Class A was $0.32 and for Class B was also $0.32, while diluted net income per ordinary share was $0.32 for both classes[369]. Cash and Investments - As of December 31, 2022, the company had approximately $234.4 million in cash held in the Trust Account, intended for the initial business combination[274]. - The company had approximately $234,364,451 in investments held in the Trust Account as of December 31, 2022, compared to $231,151,505 as of December 31, 2021[314]. - The company had a total cash balance of $70,236 at the end of 2022, down from $611,620 at the beginning of the period[323]. - The Company recorded a fair value of $234,364,451 for investments held in the Trust Account as of December 31, 2022, compared to $231,151,505 in 2021[402][403]. Business Combination and Operations - The company has until May 12, 2023, or April 12, 2024, if extensions are exercised, to complete a business combination, or it will face mandatory liquidation[275][276]. - The company has not yet selected a business combination target and has not initiated substantive discussions with any potential targets[265]. - The company plans to use substantially all funds in the Trust Account for the initial business combination and subsequent operations of the target business[274]. - The Company has until April 12, 2024, to complete a Business Combination, or it will cease operations and redeem Public Shares[335]. - The Company will proceed with a Business Combination if it has net tangible assets of at least $5,000,001 upon consummation[332]. Shareholder Activity - Shareholders redeemed 18,336,279 Class A ordinary shares at a redemption price of approximately $10.30 per share, totaling approximately $189 million[299]. - A total of 18,336,279 Class A ordinary shares were redeemed at approximately $10.30 per share, resulting in an aggregate redemption amount of approximately $189 million[412]. - After redemptions, the balance in the Company's Trust Account is approximately $48 million[412]. Liabilities and Expenses - The company incurred operating and formation expenses of approximately $1.4 million for the year ended December 31, 2022[281]. - The company incurred approximately $103,000 in administrative support expenses during the year ended December 31, 2022[288]. - The company had a working capital deficit of approximately $719,000 as of December 31, 2022[271]. - Total current liabilities increased to $1,022,731 as of December 31, 2022, from $396,793 as of December 31, 2021[314]. - The Company incurred significant costs in pursuit of its acquisition plans, raising substantial doubt about its ability to continue as a going concern[340]. Warrant and Share Information - As of December 31, 2022, there were 18,650,000 warrants outstanding, consisting of 11,500,000 Public Warrants and 7,150,000 Private Placement Warrants[386]. - The warrant liability for Public Warrants was $230,000 as of December 31, 2022, a significant decrease from $4,600,000 in 2021[402][403]. - The estimated fair value of Private Placement Warrants decreased from $3,289,000 at December 31, 2021 to $143,000 at December 31, 2022, reflecting a change of approximately 95.7%[408]. - The Company has authorized 200,000,000 Class A ordinary shares, with 23,000,000 issued and none outstanding as of December 31, 2022, all subject to possible redemption[398]. Market and Economic Conditions - Management continues to evaluate the impact of the COVID-19 pandemic and the ongoing geopolitical situation, which may affect the Company's financial position[342][343]. - The stock price increased from $9.70 in 2021 to $10.14 in 2022, representing a growth of approximately 4.5%[408]. - The volatility of the Company's ordinary shares decreased from 9.2% in 2021 to 2.6% in 2022[408]. - The risk-free interest rate increased significantly from 1.30% in 2021 to 3.91% in 2022[408].
IX Acquisition (IXAQ) - 2022 Q3 - Quarterly Report
2022-11-10 22:09
Financial Performance - For the nine months ended September 30, 2022, the company reported a net income of approximately $7.3 million, primarily due to a gain of approximately $7.0 million from the change in fair value of derivative warrant liabilities[115] - The company incurred approximately $1.1 million in operating and formation expenses for the nine months ended September 30, 2022[115] - The company incurred approximately $30,000 in administrative support expenses for the three months ended September 30, 2022[122] Cash and Capital Structure - The company raised total gross proceeds of $230 million from the Initial Public Offering of 23,000,000 Units at $10.00 per Unit[100] - The underwriters fully exercised their over-allotment option, generating additional gross proceeds of $30 million to the company[120] - The company had cash held in the Trust Account of approximately $232.6 million as of September 30, 2022, intended for the initial Business Combination[107] - As of September 30, 2022, the company had approximately $235,000 in cash held outside of the Trust Account and a working capital deficit of approximately $353,000[104] Business Combination and Strategy - The company has until April 12, 2023, to consummate a Business Combination, after which mandatory liquidation may occur if not completed[108] - The company has not selected any Business Combination target and has not initiated substantive discussions with any potential targets[99] - The company has a working capital strategy that includes using funds from the Trust Account for financing operations and potential acquisitions[107] Regulatory and Accounting Considerations - Recent accounting pronouncements discussed in the unaudited condensed financial statements[124] - The company qualifies as a smaller reporting company, thus certain market risk disclosures are not applicable[125]
IX Acquisition (IXAQ) - 2022 Q2 - Quarterly Report
2022-08-11 17:23
Fundraising and Proceeds - The company raised total gross proceeds of $230 million from its Initial Public Offering by issuing 23 million Units at $10.00 per Unit[106]. - The company generated gross proceeds of $7.15 million from the sale of 7.15 million Private Placement Warrants at $1.00 each[107]. - The underwriters fully exercised their over-allotment option, generating additional gross proceeds of $30 million to the company[127]. Financial Position - As of June 30, 2022, the company had approximately $231.5 million in cash held in the Trust Account, intended for the initial Business Combination[113]. - As of June 30, 2022, the company had a working capital deficit of approximately $119,000[110]. Income and Expenses - For the six months ended June 30, 2022, the company reported a net income of approximately $5.4 million, primarily due to a gain of $5.8 million from the change in fair value of derivative warrant liabilities[122]. - The company incurred approximately $773,000 in operating and formation expenses for the six months ended June 30, 2022[122]. - The company incurred $30,000 in administrative support expenses for the three months ended June 30, 2022[129]. Business Combination Status - The company has until April 12, 2023, to consummate a Business Combination, after which mandatory liquidation may occur if not completed[114]. - The company has not selected any Business Combination target and has not initiated substantive discussions with any potential targets[105]. Accounting and Reporting - Recent accounting pronouncements discussed in the unaudited condensed financial statements[131]. - The company qualifies as a smaller reporting company, thus market risk disclosures are not applicable[132].
IX Acquisition (IXAQ) - 2022 Q1 - Quarterly Report
2022-05-13 20:06
Financial Performance - For the three months ended March 31, 2022, the company reported a net income of $3,667,570, primarily from a gain of $4,059,500 due to changes in fair value of derivative warrant liabilities[126] - The company incurred $431,268 in operating and formation expenses during the three months ended March 31, 2022[126] IPO and Fundraising - The company raised total gross proceeds of $230 million from the Initial Public Offering (IPO) by issuing 23 million Units at $10.00 per Unit[115] - An additional $30 million was generated from the underwriters' full exercise of the over-allotment option to purchase 3 million additional Units[131] - The Trust Account holds $231,150,000 from the net proceeds of the IPO and Private Placement Warrants, invested in U.S. government treasury obligations[117] Financial Position - As of March 31, 2022, the company had $402,607 in cash held outside of the Trust Account and a working capital deficit of $137,308[120] - The company has no off-balance sheet arrangements as of March 31, 2022[128] Business Combination - The company has until April 12, 2023, to consummate a Business Combination, or it will face mandatory liquidation[120] - The company has not yet selected a Business Combination target and has not initiated substantive discussions with any potential targets[114] Risks and Uncertainties - There are significant uncertainties regarding the impact of the COVID-19 pandemic and geopolitical events on the company's financial condition and operations[123][124]
IX Acquisition (IXAQ) - 2021 Q4 - Annual Report
2022-04-13 21:31
Financial Performance - The company reported a net income of $9,337,120 for the period from March 1, 2021, through December 31, 2021, primarily due to a gain on the change in the fair value of warrant liabilities amounting to $13,216,000[267]. - Net income for the period from March 1, 2021, to December 31, 2021, was $9,337,120, resulting in a basic net income per share of $0.84 for both Class A and Class B ordinary shares[313]. - The Company incurred operating and formation costs of $615,847, leading to a loss from operations of the same amount[313]. - Basic net income per share for Class A and Class B ordinary shares was $0.84, while diluted net income per share was $0.81 for the period from inception through December 31, 2021[359]. - As of December 31, 2021, the Company reported a net income of $9,337,120[319]. Cash and Financing - Total net cash used in operating activities was $710,467, influenced by a non-cash gain on the change in fair value of warrant liabilities[269]. - As of December 31, 2021, the company had cash of $611,620 held outside the Trust Account, with a working capital surplus of $502,916[280]. - The company may need to obtain additional financing to consummate its initial business combination or due to potential redemptions of public shares[278]. - The company raised total gross proceeds of $230,000,000 from its Initial Public Offering, which included 23,000,000 Units sold at $10.00 per Unit[323]. - The company placed $231,150,000 from the net proceeds of the Initial Public Offering into a Trust Account, which will be invested in U.S. government treasury obligations[326]. Initial Public Offering (IPO) - The company generated gross proceeds of $230,000,000 from the Public Offering of 23,000,000 units at $10.00 per unit[273]. - An additional $30,000,000 was generated from the underwriters' full exercise of the over-allotment option to purchase 3,000,000 additional units[284]. - Transaction costs for the Initial Public Offering amounted to $30,639,304, including $4,000,000 in underwriting fees and $12,100,000 in deferred underwriting fees[325]. - The Company recognized offering costs of $2,120,549, which were expensed in the statement of operations[313]. - The Company incurred offering costs of $30,639,304 related to the Initial Public Offering, with $28,518,755 charged to shareholders' equity and $2,120,549 expensed immediately[353]. Warrant Liabilities - The Company evaluated its warrant liabilities and concluded they should be recorded as derivative liabilities, measured at fair value[361]. - The Company has a warrant liability of $4,600,000 for Public Warrants and $3,289,000 for Private Placement Warrants, totaling $7,889,000 in liabilities[405]. - The fair value of Public Warrants was $0.40 per warrant as of December 31, 2021, based on observable market quotes[407]. - The estimated fair value of the Private Placement Warrant liabilities is determined using Level 3 inputs, with changes recognized in the statement of operations[408]. - The total change in fair value of warrant liabilities recognized was $13,216,000 from March 1, 2021, through December 31, 2021[409]. Business Operations and Future Outlook - The company does not expect to generate operating revenues until after the completion of its initial business combination[266]. - Management expressed substantial doubt about the Company's ability to continue as a going concern due to insufficient cash and working capital as of December 31, 2021[304]. - The Company has a deadline of April 12, 2023, to complete its initial Business Combination or return funds to public shareholders[326]. - The Company has until April 12, 2023, to complete a Business Combination, or it will cease operations and redeem Public Shares at a price based on the Trust Account balance[333]. - The Company has committed to loan up to $1,400,000 for working capital purposes, convertible into Private Placement Warrants at $1.00 per warrant[386]. Shareholder Information - The Company reported a total of 23,000,000 Class A ordinary shares subject to possible redemption at a redemption value of $10.05 per share, amounting to $231,151,505[311]. - The Class A ordinary shares subject to possible redemption totaled $231,151,505 as of December 31, 2021, after accounting for various adjustments[352]. - The company will provide public shareholders the opportunity to redeem their shares for a pro rata portion of the Trust Account, initially valued at $10.05 per Public Share[329]. - The Company has 23,000,000 Class A ordinary shares with a redemption feature, which are classified outside of permanent equity due to SEC guidance[349]. - The initial shareholders agreed to a lock-up period for Founder Shares until one year after a Business Combination or under certain price conditions[378]. Administrative and Operational Expenses - The company incurred expenses of $26,301 under an administrative support agreement for office space and services during the reporting period[286]. - The Company incurred additional operational expenses of $23,699 paid to IX Acquisition Services LLC during the same period[385]. - The Company has not commenced any operations as of December 31, 2021, with all activities related to its formation and Initial Public Offering[322]. - The company is subject to risks associated with being an early stage and emerging growth company[321]. - Management continues to assess the impact of the COVID-19 pandemic, which may negatively affect the Company's financial position and operations[339].
IX Acquisition (IXAQ) - 2021 Q3 - Quarterly Report
2021-11-22 22:06
Financial Performance - The company reported a net loss of $4,395 for the three months ended September 30, 2021, resulting from operating and formation costs [94]. - Cumulative net loss from inception (March 1, 2021) through September 30, 2021, amounted to $15,572, attributed to operating and formation costs [95]. - Net cash used in operating activities was $12,542, primarily due to the net loss and changes in prepaid expenses [96]. - The company does not expect to generate operating revenues until after completing its initial business combination [93]. Financing Activities - The company generated $29,323 in net cash from financing activities, driven by $156,742 in proceeds from a Promissory Note, offset by offering costs of $127,419 [97]. - The Initial Public Offering (IPO) on October 12, 2021, raised gross proceeds of $230,000,000 from the sale of 23,000,000 units at $10.00 per unit [98]. - An additional $30,000,000 was generated from the underwriters' full exercise of the over-allotment option for 3,000,000 units at the same offering price [107]. - The company placed $231,150,000 from the IPO net proceeds into a trust account for future business combinations [100]. - The outstanding balance of the Promissory Note was $168,242 as of September 30, 2021, which was repaid on October 12, 2021 [106]. Off-Balance Sheet Arrangements - As of September 30, 2021, the company had no off-balance sheet arrangements [104].